1 |
Zha, J., Harada, H., Yang, E., Jockel, J. and Korsmeyer, S. J. (1996). Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3- not Bcl-XL. Cell 87, 619-628
DOI
ScienceOn
|
2 |
Altomare, D. A. and Testa, J. R. (2005). Perturbations of the AKT signaling pathway in human cancer. Oncogene 24, 7455-7464
DOI
ScienceOn
|
3 |
Burke, M. D., Thompson, S., Elcombe, C. R., Halpert, J., Haaparanta, T. and Mayer, R. T. (1985). Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem. Pharmacol. 34, 3337-3345
DOI
ScienceOn
|
4 |
Cecchinato, V., Chiaramonte, R., Nizzardo, M., Cristofaro, B., Basile, A., Sherbet, G. V. and Comi, P. (2007). Resveratrolinduced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells. Biochem. Pharmacol. 74, 1568-1574
DOI
ScienceOn
|
5 |
Chun, Y. J., Kim, M. Y. and Guengerich, F. P. (1999). Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem. Biophys. Res. Commun. 262, 20-24
DOI
ScienceOn
|
6 |
Chang, T. K., Lee, W. B. and Ko, H. H. (2000). Trans-resveratrol modulates the catalytic activity and mRNA expression of the procarcinogen-activating human cytochrome P450 1B1. Can. J. Physiol. Pharmacol. 78, 874-881
DOI
|
7 |
Chun, Y. J. and Kim, S. (2003). Discovery of cytochrome P450 1B1 inhibitors as new anti-cancer agents. Med. Res. Rev. 23, 657-668
DOI
ScienceOn
|
8 |
Chun, Y. J., Kim, S., Kim, D., Lee, S. K. and Guengerich, F. P. (2001a). A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. Cancer Res. 61, 8164-8170
|
9 |
Chun, Y. J., Ryu, S. Y., Jeong, T. C. and Kim, M. Y. (2001b). Mechanism based inhibition of human cytochrome P450 1A1 by rhapontigenin. Drug Metab. Dispos. 29, 389-393
|
10 |
Fleming, I., Fisslthaler, B. and Busse, R. (1995). Calcium signaling in endothelial cells involves activation of tyrosine kinases and leads to activation of MAP kinases. Circ. Res. 76, 522-529
DOI
ScienceOn
|
11 |
Geahlen, R. L. and McLaughlin, J. L. (1989). Piceatannol (3,4,3',5'-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor. Biochem. Biophys. Res. Commun. 165, 241-245
DOI
ScienceOn
|
12 |
Gross, A., McDonnell, J. M. and Korsmeyer, S. J. (1999). Bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 13, 1899-1911
DOI
ScienceOn
|
13 |
Guengerich, F. P. and Shimada, T. (1991). Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 4,381-407
DOI
ScienceOn
|
14 |
Johnson, N. C., Dan, H. C., Cheng, J. Q. and Kruk, P. A. (2004). BRCA1 185delAG mutation inhibits Akt-dependent, IAPmediated caspase 3 inactivation in human ovarian surface epithelial cells. Exp. Cell Res. 298, 9-16
DOI
ScienceOn
|
15 |
Hsieh, T., Juan, G., Darzynkiewicz, Z. and Wu, J. M. (1999). Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res. 59, 2596-2601
|
16 |
Li, Y., Liu, J. Y., Liu, X. P., Xing, K. F., Wang Y., Li, F. Y. and Yao, L. (2006). Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated Akt and caspase-9. Appl. Biochem. Biotechnol. 135,181-192
DOI
|
17 |
Kadlubar, F. F. and Hammons, G. J. (1987). The role of cytochrome P-450 in the metabolism of chemical carcinogens. In: Mammalian cytochromes P-450. Boca Raton: CRC Press; 1987. pp 81-130
|
18 |
Aziz, M. H., Nihal, M., Fu, V. X., Jarrard, D. F. and Ahmad, N. (2006). Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins. Mol. Cancer Ther. 5, 1335-1341
DOI
ScienceOn
|
19 |
Lee, S. H., Ryu, S. Y., Kim, H. B., Kim, M. Y. and Chun, Y. J. (2002). Induction of apoptosis by 3,4'-dimethoxy-5-hydroxystilbene in human promyeloid leukemic HL-60 cells. Planta Med. 68, 123-127
DOI
ScienceOn
|
20 |
Peters, J. D., Furlong, M. T., Asai, D. J., Harrison, M. L. and Geahlen, R. L. (1996). Syk, activated by cross-linking the Bcell antigen receptor, localises to the cytosol where it interacts with and phosphorylates a-tubulin on tyrosine. J. Biol. Chem. 271, 4755-4762
DOI
|
21 |
So, K. S., Oh, J. E., Han, J. H., Jung, H. K., Lee, Y. S., Kim, S. H., Chun, Y. J. and Kim, M. Y. (2008). Induction of apoptosis by a stilbene analog involves Bax translocation regulated by p38 MAPK and Akt. Arch. Pharm. Res. 31, 438-444
DOI
ScienceOn
|
22 |
Wrighton, S. A. and Stevens, J. C. (1992). The human hepatic cytochrome P450 involved in drug metabolism. Crit. Rev. Toxicol. 22,1-21
DOI
|
23 |
Zhou, H., Li, X. M., Meinkoth, J. and Pittman, R. N. (2000). Akt regulates cell survival and apoptosis at a postmitochondrial level. J. Cell. Biol. 151, 483-494
DOI
|
24 |
Surh, Y. J., Hurh, Y. J., Kang, J. Y., Lee, E., Kong, G. and Lee, S. J. (1999). Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett. 140, 1-10
DOI
ScienceOn
|
25 |
Ferrigni, N. R., McLaughlin, J. L., Powell, R. G. and Smith, C. R. (1984). Isolation of piceatannol as the antileukemic principle from the seeds of euphorbia lagascae. J. Nat. Prod. 47, 347-352
DOI
|
26 |
Tsuruta, F., Masuyama, N. and Gotoh Y. (2002). The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J. Biol. Chem. 277, 14040-14047
DOI
ScienceOn
|
27 |
Benistant, C., Chapuis, H. and Roche, S. (2000). A specific function for phosphatidylinositol 3-kinase alpha (p85 alphap110 alpha) in cell survival and for phosphatidylinositol 3- kinase beta (p85 α-p110 α) in de novo DNA synthesis of human colon carcinoma cells. Oncogene 19, 5083-5090
DOI
|
28 |
Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordan, J., Bellacosa, A., Tsichlis, P. N. and Hay, N. (1997). The PI3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11, 701-713
DOI
|
29 |
Tsan, M. F., White, J. E., Maheshwari, J. G., Bremner, T. A. and Sacco, J. (2000). Resveratrol induces Fas signalling-independent apoptosis in THP-1 human monocytic leukemia cells. Brit. J. Haematol. 109, 405-412
DOI
|
30 |
Guengerich, F. P., Martin, M. V., Guo, Z. and Chun, Y. J. (1996). Purification of functional recombinant P450s from bacteria. Methods Enzymol. 272, 35-44
DOI
|
31 |
Chun, Y. J., Lee, S.K. and Kim, M. Y. (2005). Modulation of human cytochrome P450 1B1 expression by 2,4,3',5'-tetramethoxystilbene. Drug Metab. Dispos. 33, 1771-1776
DOI
ScienceOn
|
32 |
Gardai, S. J., Hildeman, D. A., Frankel, S. K., Whitlock, B. B., Frasch, S. C., Borregaard, N., Marrack, P., Bratton, D. L. and Henson, P. M. (2004). Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J. Biol. Chem. 279, 21085-21095
DOI
ScienceOn
|
33 |
Su., L. and David, M. (2000). Distinct mechanisms of STAT phosphorylation via the interferon-a/b receptor, selective inhibition of STAT3 and STAT5 by piceatannol. J. Biol. Chem. 275, 12661-12666
DOI
ScienceOn
|
34 |
Lee, S. K., Kim, Y., Kim, M. Y., Chun, Y. J. and Kim, S. (2004). Potent inhibition of recombinant human cytochrome P-450 1A1 by pentamethoxystilbene. J. Toxicol. Environ. Health Part A 67, 1987-2000
DOI
ScienceOn
|
35 |
Omura, T. and Sato, R. (1964). The carbon-monoxide binding pigment of liver microsomes. J. Biol. Chem. 239, 2370-2378
|
36 |
Parikh, A., Gillam, E. M. and Guengerich, F. P. (1997). Drug metabolism by Escherichia coli expressing human cytochromes P450. Nat. Biotechnol. 15, 784-788
DOI
ScienceOn
|